Prognosis Prediction of Diffuse Large B-Cell Lymphoma in F-FDG PET Images Based on Multi-Deep-Learning Models.

Journal: IEEE journal of biomedical and health informatics
PMID:

Abstract

Diffuse large B-cell lymphoma (DLBCL), a cancer of B cells, has been one of the most challenging and complicated diseases because of its considerable variation in clinical behavior, response to therapy, and prognosis. Radiomic features from medical images, such as PET images, have become one of the most valuable features for disease classification or prognosis prediction using learning-based methods. In this paper, a new flexible ensemble deep learning model is proposed for the prognosis prediction of the DLBCL in F-FDG PET images. This study proposes the multi-R-signature construction through selected pre-trained deep learning models for predicting progression-free survival (PFS) and overall survival (OS). The proposed method is trained and validated on two datasets from different imaging centers. Through analyzing and comparing the results, the prediction models, including Age, Ann abor stage, Bulky disease, SUVmax, TMTV, and multi-R-signature, achieve the almost best PFS prediction performance (C-index: 0.770, 95% CI: 0.705-0.834, with feature adding fusion method and C-index: 0.764, 95% CI: 0.695-0.832, with feature concatenate fusion method) and OS prediction (C-index: 0.770 (0.692-0.848) and 0.771 (0.694-0.849)) on the validation dataset. The developed multiparametric model could achieve accurate survival risk stratification of DLBCL patients. The outcomes of this study will be helpful for the early identification of high-risk DLBCL patients with refractory relapses and for guiding individualized treatment strategies.

Authors

  • Chunjun Qian
    School of Science, Nanjing University of Science and Technology, Jiangsu, China.
  • Chong Jiang
  • Kai Xie
    National Demonstration Center for Experimental Electrical and Electronic Education, Yangtze University, Jingzhou 434023, China. 500646@yangtzeu.edu.cn.
  • Chongyang Ding
    Department of Nuclear Medicine, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Yue Teng
    Haidian Maternal & Child Health Hospital Nutrition Clinic, Beijing 100080, China.
  • Jiawei Sun
    Department of Bioengineering, Stanford University, CA, 94305, USA.
  • Liugang Gao
    Radiotherapy Department, Second People's Hospital of Changzhou, Nanjing Medical University, Changzhou, 213003, China.
  • Zhengyang Zhou
    Suzhou Institute for Advanced Research, University of Science and Technology of China, Suzhou 215123, China; School of Computer Science and Technology, University of Science and Technology of China, Hefei 230026, China.
  • Xinye Ni
    Radiotherapy Department, Second People's Hospital of Changzhou, Nanjing Medical University, Changzhou, 213003, China. nxy@njmu.edu.cn.